Literature DB >> 25616721

Editorial: Siegfried Hoyer's concept of Alzheimer pathophysiology.

Lutz Frölich1, Walter E Müller, Peter Riederer.   

Abstract

The concept of central insulin resistance and dysfunctional insulin signaling in Alzheimer's Disease (AD) has been developed by Siegfried Hoyer in 1985-2000. It is widely recognized that the mechanisms underlying neuronal energy deficiency and in particular to elucidate insulin/insulin receptor cascade deficiencies are some of the most relevant proximate characteristics of sporadic AD. The imbalance between cerebral oxygen utilization and cerebral glucose utilization may cause rise in reactive oxygen species production and this might be causal for synapse degeneration. This concept has been substantiated by work on postmortem Alzheimer brains and has been translated back into the streptozotozin animal model, which has stimulated much further research by other researchers. Finally, the insulin hypothesis of Alzheimer's disease has currently advanced into a potential therapeutic avenue.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25616721     DOI: 10.1007/s00702-015-1371-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  21 in total

1.  [THE CARBOHYDRATE METABOLISM OF THE HUMAN BRAIN. I. STUDIES WITH SUBSTRATE-SPECIFIC ENZYMATIC METHODS IN NORMAL BRAIN CIRCULATION].

Authors:  U GOTTSTEIN; A BERNSMEIER; I SEDLMEYER
Journal:  Klin Wochenschr       Date:  1963-10-01

2.  US government sets out Alzheimer's plan.

Authors:  Meredith Wadman
Journal:  Nature       Date:  2012-05-22       Impact factor: 49.962

3.  Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus.

Authors:  K Plaschke; S Hoyer
Journal:  Int J Dev Neurosci       Date:  1993-08       Impact factor: 2.457

4.  [Cerebral blood flow and brain metabolism findings in neuropsychiatric patients].

Authors:  S Hoyer; K Becker
Journal:  Nervenarzt       Date:  1966-07       Impact factor: 1.214

5.  Changes in pyruvate dehydrogenase complex (PDHc) activity and [3H]QNB-receptor binding in rat brain subsequent to intracerebroventricular injection of bromopyruvate.

Authors:  L Frölich; M Strauss; J Kornhuber; S Hoyer; S Sorbi; P Riederer; L Amaducci
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1990

6.  A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease.

Authors:  L Frölich; D Blum-Degen; P Riederer; S Hoyer
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

7.  Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.

Authors:  L Frölich; D Blum-Degen; H G Bernstein; S Engelsberger; J Humrich; S Laufer; D Muschner; A Thalheimer; A Türk; S Hoyer; R Zöchling; K W Boissl; K Jellinger; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

Review 8.  What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research.

Authors:  Melita Salkovic-Petrisic; Ana Knezovic; Siegfried Hoyer; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2012-08-12       Impact factor: 3.575

9.  Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type.

Authors:  S Hoyer; R Nitsch
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

10.  Holeboard maze-learning deficits and brain monoaminergic neurotransmitter concentrations in rats after intracerebroventricular injection of 3-bromopyruvate.

Authors:  L Froelich; A Ding; S Hoyer
Journal:  Pharmacol Biochem Behav       Date:  1995-08       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.